Electrophysiological Characteristics of the Right Middle Pulmonary Vein and the Impact of Additional Carina Ablation

Pacing Clin Electrophysiol. 2026 Jun 7. doi: 10.1111/pace.70309. Online ahead of print.ABSTRACTBACKGROUND: Previous studies have demonstrated electrical connections between ipsilateral pulmonary veins (PVs). This study aimed to characterize the electrophysiological features of right middle pulmonary

Y Yue Qiu

Outcomes of Patients With High-Risk Plaques Treated With a Bioresorbable Magnesium Scaffold: Insights From the BIOMAG-I Study

Catheter Cardiovasc Interv. 2026 Jun 7. doi: 10.1002/ccd.70655. Online ahead of print.ABSTRACTBACKGROUND: Early identification and targeted treatment of coronary lesions at higher risk of future events remains a major unmet need in coronary artery disease research. Invasive treatment of such plaques

P Pablo M Rubio

Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK

Echo Res Pract. 2026 Jun 8;13(1):20. doi: 10.1186/s44156-026-00119-1.ABSTRACTBACKGROUND: The 2022 ESC/ERS guidelines redefined pulmonary hypertension (PH) as a mean pulmonary artery pressure (mPAP) >20 mmHg on right heart catheterisation (RHC). Echocardiography, using metrics such as tricuspid regur

N Nina Karia

International practices and variability in right heart echocardiography: results from the RVNet(Work) international survey

Echo Res Pract. 2026 Jun 8;13(1):22. doi: 10.1186/s44156-026-00121-7.ABSTRACTBACKGROUND: The assessment of the right heart (RH) plays a central role in the diagnosis and management of cardiovascular and pulmonary diseases. Although current guidelines have improved standardization, there is anecdotal

H Harry Magunia

Predictive value of the triglyceride glucose index-a body shape index (TyG-ABSI) for cardiovascular disease and its comparison with other TyG-related obesity indices: a study based on the China health and retirement longitudinal study (CHARLS) cohort

Cardiovasc Diabetol. 2026 Jun 7. doi: 10.1186/s12933-026-03241-w. Online ahead of print.ABSTRACTBACKGROUND: Insulin resistance (IR) and obesity are recognized as major drivers of cardiovascular disease (CVD). The triglyceride-glucose index-a body shape index (TyG-ABSI), a novel metric integrating li

X Xinying Liu

Combination of GLP-1 receptor agonists and SGLT2 inhibitors in cardiometabolic disease: synergistic, additive, or non-additive effects? A narrative review

Cardiovasc Diabetol. 2026 Jun 7. doi: 10.1186/s12933-026-03239-4. Online ahead of print.ABSTRACTBACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are two novel classes of glucose-lowering agents with proven cardiometabo

E Eirini Stamouli

Smartwatch-derived exercise metrics as predictors of early hypertension: a prospective observational study

BMC Cardiovasc Disord. 2026 Jun 8. doi: 10.1186/s12872-026-06073-4. Online ahead of print.ABSTRACTBACKGROUND: Early identification of individuals at risk for hypertension is essential for effective cardiovascular disease. Physiological and activity metrics derived from consumer smartwatches may offe

E Esma Selva Ateş Ceyhun

Lipoprotein(a) and Peripheral Artery Disease as Independent Predictors of Arterial Stiffness in Patients With Hypertension: A Single-Center Cross-Sectional Study

J Clin Hypertens (Greenwich). 2026 Jun;28(6):e70309. doi: 10.1111/jch.70309.ABSTRACTCarotid-femoral pulse-wave velocity (cfPWV) is a marker of central arterial stiffness and an established predictor of cardiovascular risk in hypertension. Although elevated lipoprotein(a) [Lp(a)] concentrations and p

B Bibombe P Mwipatayi

Impact of guideline definitions on right ventricular diameter in echocardiography: an automated analysis in controls and patients with pulmonary hypertension

Echo Res Pract. 2026 Jun 8;13(1):21. doi: 10.1186/s44156-026-00118-2.ABSTRACTBACKGROUND: To improve standardization, the 2025 American Association of Echocardiography (ASE) guidelines revised the definitions of right ventricular (RV) basal and mid diameters, revising the 2010 ASE and European Societ

F Frida N Hermansson

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial

Nat Med. 2026 Jun 7. doi: 10.1038/s41591-026-04479-3. Online ahead of print.ABSTRACTSurvodutide is a glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treating obesity and related diseases. The SYNCHRONIZE-MASLD phase 3, randomized, double-blind, placebo-control

L Lee M Kaplan

Role of Nrf2 and NQO1 genetic variants in cardiometabolic diseases: an 8-year prospective study of genetic, dietary, biochemical, and oxidative stress markers in Iranian Kurdish Adults

Sci Rep. 2026 Jun 7. doi: 10.1038/s41598-026-56799-6. Online ahead of print.ABSTRACTThis study assessed the association between Nrf2 (rs6721961) and NQO1 (rs1800566) polymorphisms and cardiometabolic diseases (CMDs) in the Kurdish population of Iran. We analyzed 509 Kurdish individuals. Biochemical

M Maryam Kohsari

Glycemic control and cardiovascular health in prediabetes: untiring exploration towards consensus

Zhonghua Yi Xue Za Zhi. 2026 Jun 9;106(21):2091-2095. doi: 10.3760/cma.j.cn112137-20260323-00777.ABSTRACTDiabetes-related cardiovascular diseases carry high rates of disability and mortality, and their medical costs are prohibitively expensive. Shifting management upstream is imperative. The risk of

G G W Li

Epidemiology of Cardiovascular Disease in Pregnancy in Japan - Analysis of a Nationwide Perinatal Database 2014-2023

Circ J. 2026 Jun 5. doi: 10.1253/circj.CJ-26-0154. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular disease (CVD) is an increasingly important contributor to maternal morbidity and mortality worldwide, but contemporary nationwide data in Japan remain limited.METHODS AND RESULTS: We conducted

M Masafumi Nii

MYC-Driven Glycolysis in TNFRSF4+ CD4+ T Cells Underlies Heightened Rejection Susceptibility of Cardiac vs. Renal Allografts

Circ J. 2026 Jun 5. doi: 10.1253/circj.CJ-25-0880. Online ahead of print.ABSTRACTBACKGROUND: Cardiac allografts show poorer long-term survival and decreased tolerance compared to renal allografts, but the underlying mechanisms remain unclear.METHODS AND RESULTS: We established heterotopic heart and

P Peiyuan Li

Reply to Letter to the Editor regarding "Phenotypic and Structural Granularity in Cardiogeriatric Risk Stratification"

No abstractHeart Lung Circ. 2026 Jun;35(6):e86-e87. doi: 10.1016/j.hlc.2026.04.007.NO ABSTRACTPMID:42252148 | DOI:10.1016/j.hlc.2026.04.007

J Julee McDonagh

Letter to the Editor "Phenotypic and Structural Granularity in Cardiogeriatric Risk Stratification" regarding: "Cardiovascular Disease, Frailty, and Multimorbidity as Predictors of Adverse Outcomes in Older Adults Admitted to Acute Geriatric Settings: A Secondary Analysis" by McDonagh et al. Heart Lung Circ. 2026;35:795-805

No abstractHeart Lung Circ. 2026 Jun;35(6):e84-e85. doi: 10.1016/j.hlc.2026.04.014.NO ABSTRACTPMID:42252147 | DOI:10.1016/j.hlc.2026.04.014

N Natalia Kulicka

Advancing Cardiogeriatric Care and Frailty Science in Cardiovascular Disease: From Basic Science to Implementation

No abstractHeart Lung Circ. 2026 Jun;35(6):709-712. doi: 10.1016/j.hlc.2026.05.003.NO ABSTRACTPMID:42252145 | DOI:10.1016/j.hlc.2026.05.003

J Julee McDonagh

Does HDL-C matter when predicting risk of cardiovascular disease in older people with type 2 diabetes?

No abstractEur J Prev Cardiol. 2026 Jun 8:zwag290. doi: 10.1093/eurjpc/zwag290. Online ahead of print.NO ABSTRACTPMID:42252099 | DOI:10.1093/eurjpc/zwag290

B Baris Gencer

Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease

Brain. 2026 Jun 8:awag183. doi: 10.1093/brain/awag183. Online ahead of print.ABSTRACTSevere neuropathies with predominant involvement of motor fibers can resemble lower motor neuron disease (LMND) phenotypes. Given the fatal prognosis of LMND, identifying underlying autoimmune syndromes is crucial t

F Friederike A Arlt

FDG-PET/CT for cardiovascular disease: A systems-level imaging framework linking inflammation, metabolism, and neural stress

J Cardiol. 2026 Jun 6:S0914-5087(26)00108-5. doi: 10.1016/j.jjcc.2026.06.002. Online ahead of print.ABSTRACTAtherosclerotic cardiovascular disease (ACVD) is increasingly recognized as a chronic inflammatory disorder involving complex interactions across vascular, metabolic, immune, and neurobiologic

N Nobuhiro Tahara

Cystathionine γ-lyase deficiency exacerbates high-fat diet-induced kidney and liver injury associated with disrupted glutathione homeostasis

Free Radic Biol Med. 2026 Jun 6:S0891-5849(26)00868-3. doi: 10.1016/j.freeradbiomed.2026.06.017. Online ahead of print.ABSTRACTObesity is a major risk factor for chronic kidney disease (CKD), partly mediated by oxidative stress. The liver is the primary source of glutathione (GSH), a key antioxidant

G Gibong Jang

Peripheral Artery Disease as a Predictor of Poor In-hospital Outcomes in Patients with Acute Myocardial Infarction

Am J Med Sci. 2026 Jun 6:S0002-9629(26)00223-5. doi: 10.1016/j.amjms.2026.06.003. Online ahead of print.ABSTRACTBACKGROUND: Research has demonstrated that individuals with acute myocardial infarction (AMI) and peripheral artery disease (PAD) experience more complications compared to those with AMI o

Y Yousef Alsmairat

Radiation therapy in adolescents and young adults (AYA): contemporary evidence on utilization, outcomes, late toxicities, and second malignant neoplasms - A comprehensive systematic review and synthesis

Radiother Oncol. 2026 Jun 6:111638. doi: 10.1016/j.radonc.2026.111638. Online ahead of print.ABSTRACTAdolescent and young adult (AYA; 15-39 years) cancer survivors face decades of potential life-years, making radiotherapy (RT) modality and technique selection central determinants of long-term health

A Anna Simbirova

Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM

J Card Fail. 2026 Jun 6:S1071-9164(26)00257-5. doi: 10.1016/j.cardfail.2026.03.036. Online ahead of print.ABSTRACTBACKGROUND: The Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) is the first patient-reported outcome tool to measure cardinal symptoms of HCM. We examined the impact of mavaca

S Sara Saberi